Screening for hereditary haemochromatosis in patients undergoing knee arthroplasty : a retrospective cohort study of 2,035 patients

• Published in: Bone & joint open 2021-12, Vol.2 (12), p.1062-1066
• Main Authors: Krasin, Elisha, Gold, Aviram, Morgan, Samuel, Warschawski, Yaniv
• Format: Article
• Language: English
• Subjects: arthroplasty surgery; cirrhosis; diabetes; ferritin; genetic testing; haemochromatosis; hereditary haemochromatosis; iron; joint disease; Knee; knee arthroplasty; Oral Tranexamic Acid; osteoarthritis; osteoarthritis (oa); Randomized Controlled Trial; serum; Total Blood Loss; Total Knee Arthroplasty; transferrin saturation
• ISSN: 2633-1462; 2633-1462
• DOI: 10.1302/2633-1462.212.BJO-2021-0162.R1

Hereditary haemochromatosis is a genetic disorder that is caused by several known mutations in the human homeostatic iron regulator protein ( ) gene. Abnormal accumulation of iron causes a joint disease that resembles osteoarthritis (OA), but appears at a relatively younger age and is accompanied by cirrhosis, diabetes, and injury to other organs. Increased serum transferrin saturation and ferritin levels are known markers of haemochromatosis with high positive predictive values. We have retrospectively analyzed the iron studies of a cohort of 2,035 patients undergoing knee joint arthroplasty due to OA. No patients had gene C282Y, S65C, or H63D mutations testing. In total, 18 patients (2.96%) of the male cohort and 51 (3.58%) of the female cohort had pathologically increased ferritin levels that may be indicative of haemochromatosis. Seven patients (0.34%) had serum transferrin saturation above 45%. The awareness for the diagnosis of this disorder in Orthopaedics is low and needs improvement. Osteoarthritic patients undergoing knee arthroplasty should be routinely screened for haemochromatosis by iron studies and referred to genetic testing when needed. Level of evidence: Level III - Retrospective cohort study. Cite this article:  2021;2(12):1062-1066.